Center for Neuroinflammation and Cardiometabolic Disease, Georgia State University, Atlanta, Georgia, United States.
Am J Physiol Endocrinol Metab. 2023 Jul 1;325(1):E72-E82. doi: 10.1152/ajpendo.00083.2023. Epub 2023 Jun 7.
Previous studies have shown that very low dose, acute, single peripheral leptin injections fully activate arcuate nucleus signal transducer and activator of transcription 3 (STAT3), but ventromedial hypothalamus (VMH) pSTAT3 continues to increase with higher doses of leptin that inhibit food intake. The lowest dose that inhibited intake increased circulating leptin 300-fold whereas food intake is inhibited by chronic peripheral leptin infusions that only double circulating leptin. This study examined whether the pattern of hypothalamic pSTAT3 was the same in leptin-infused rats as in leptin-injected rats. Male Sprague-Dawley rats received intraperitoneal infusions of 0, 5, 10, 20, or 40 µg leptin/day for 9 days. The highest dose of leptin increased serum leptin by 50-100%, inhibited food intake for 5 days, but inhibited weight gain and retroperitoneal fat mass for 9 days. Energy expenditure, respiratory exchange ratio, and brown fat temperature did not change. pSTAT3 was quantified in hypothalamic nuclei and the nucleus of the solitary tract (NTS) when food intake was inhibited and when it had returned to control levels. There was no effect of leptin on pSTAT3 in the medial or lateral arcuate nucleus or in the dorsomedial nucleus of the hypothalamus. VMH pSTAT3 was increased only at when food intake was inhibited, but NTS pSTAT3 was increased at both 4 and 9 days of infusion. These results suggest that activation of leptin VMH receptors contributes to the suppression of food intake, but that hindbrain receptors contribute to a sustained change in metabolism that maintains a reduced weight and fat mass. Low-dose, chronic peripheral infusions of leptin produced an initial, transient inhibition of food intake that correlated with signal transducer and activator of transcription 3 (STAT3) activation in the ventromedial hypothalamus (VMH) and nucleus of the solitary tract (NTS). When intake normalized, but weight remained suppressed, the NTS was the only area that remained activated. These data suggest that leptin's primary function is to reduce body fat, that hypophagia is a means of achieving this and that different areas of the brain are responsible for the progressive response.
先前的研究表明,单次外周给予极低剂量的瘦素即可充分激活弓状核信号转导子和转录激活子 3(STAT3),但随着瘦素剂量的增加(其会抑制摄食),腹内侧下丘脑(VMH)的 pSTAT3 持续增加。抑制摄食所需的最低剂量使循环瘦素增加 300 倍,而慢性外周给予瘦素会使循环瘦素增加一倍,但可抑制摄食。本研究旨在探究给予肥胖大鼠外周输注瘦素时,其下丘脑 pSTAT3 的模式是否与注射瘦素的大鼠相同。雄性 Sprague-Dawley 大鼠接受 0、5、10、20 或 40μg/天的腹腔内输注,共 9 天。最高剂量的瘦素使血清瘦素增加 50-100%,抑制摄食 5 天,但抑制体重增加和腹膜后脂肪量 9 天。能量消耗、呼吸交换率和棕色脂肪温度均无变化。当抑制摄食和摄食恢复到对照水平时,在下丘脑核和孤束核(NTS)中定量分析 pSTAT3。瘦素对内侧或外侧弓状核或下丘脑背内侧核的 pSTAT3 没有影响。只有在抑制摄食时,VMH 的 pSTAT3 才会增加,但在输注 4 天和 9 天时,NTS 的 pSTAT3 都会增加。这些结果表明,瘦素 VMH 受体的激活有助于抑制摄食,但后脑受体有助于持续改变代谢,从而维持体重和脂肪量的减少。低剂量、慢性外周给予瘦素可最初短暂抑制摄食,这与摄食行为发生变化有关。在摄食行为恢复正常但体重仍受抑制时,NTS 是唯一保持激活的区域。这些数据表明,瘦素的主要功能是减少体脂肪,而摄食减少是实现这一目标的一种手段,不同的脑区负责这种渐进性反应。